Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium
暂无分享,去创建一个
Hannah Yang | Shan Wang-Gohrke | Honglin Song | Malcolm C Pike | Georgia Chenevix-Trench | Argyrios Ziogas | Jolanta Lissowska | Hoda Anton-Culver | Jenny Chang-Claude | Paul D P Pharoah | Daniel O Stram | Ellen L Goode | Brooke L Fridley | Montserrat Garcia-Closas | Stephen Chanock | David C Whiteman | Alice S Whittemore | Lydia Quaye | Thomas A Sellers | Valerie McGuire | Rebecca Hein | Edwin S Iversen | Joellen M Schildkraut | Jeffrey R Marks | Celeste Leigh Pearce | Ian Jacobs | A. Whittemore | M. Pike | R. Vierkant | T. Sellers | J. Chang-Claude | S. Chanock | M. García-Closas | B. Fridley | E. Goode | A. Berchuck | E. Iversen | P. Pharoah | D. Stram | L. Wilkens | A. Ziogas | H. Anton-Culver | I. Jacobs | G. Chenevix-Trench | J. Lissowska | J. Beesley | J. Cunningham | M. Goodman | R. Hein | A. Wu | S. Wang-gohrke | S. Gayther | D. Cramer | L. Quaye | D. J. Van Den Berg | R. Ness | D. Whiteman | R. Dicioccio | J. Doherty | J. Schildkraut | K. Moysich | A. Green | C. Pearce | Hannah P. Yang | M. Carney | V. McGuire | M. Rossing | Honglin Song | C. Phelan | P. Webb | G. Lurie | R. Edwards | E. Høgdall | C. Høgdall | S. Ramus | Xiao Qing Chen | K. Terry | S. Krüger Kjaer | Andrew Berchuck | Marc T Goodman | Julie M Cunningham | Penelope M Webb | Susan J Ramus | Estrid Hogdall | Richard A DiCioccio | Simon A Gayther | Jonathan Beesley | Anna H Wu | Daniel W Cramer | Jennifer A Doherty | Mary Anne Rossing | Galina Lurie | Lynne R Wilkens | Robert A Vierkant | Michael E Carney | Susanne Krüger Kjaer | Jan Blaakaer | Claus Hogdall | Kathryn L Terry | Ya-Yu Tsai | Roberta B Ness | Robert P Edwards | Catherine M Phelan | Kirsten Moysich | Adele C Green | David J Van Den Berg | J. Blaakaer | J. Marks | Ya‐Yu Tsai | A. Green
[1] A. Whittemore,et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis , 2008, British Journal of Cancer.
[2] Malcolm C Pike,et al. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. , 2005, Journal of the National Cancer Institute.
[3] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[4] F. Hanisch,et al. O-Glycosylation of the Mucin Type , 2001, Biological chemistry.
[5] Shan Wang-Gohrke,et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. , 2009, Human molecular genetics.
[6] R. Vierkant,et al. Association of SNPs in glycosylation genes with risk of epithelial ovarian cancer , 2007 .
[7] S. Chanock,et al. Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study , 2007, BMC Cancer.
[8] A. Whittemore,et al. Consortium analysis of 7 candidate SNPs for ovarian cancer , 2008, International journal of cancer.
[9] Francesmary Modugno,et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. , 2007, Cancer research.
[10] A. Whittemore,et al. Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium , 2009, British Journal of Cancer.
[11] A. Whittemore,et al. Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women , 2008, Cancer Epidemiology Biomarkers & Prevention.
[12] Mark Liebow,et al. Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[13] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[14] A. Berchuck,et al. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. , 2008, Advances in experimental medicine and biology.
[15] Kit S Lam,et al. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. , 2008, Journal of proteome research.
[16] D. Easton,et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. , 2009, Human molecular genetics.
[17] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[18] Mark Sherman,et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. , 2009, Cancer research.
[19] D. Weghuis,et al. Genomic organization and chromosomal localization of three members of the UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase family. , 1998, Glycobiology.